0001209191-19-033190.txt : 20190529 0001209191-19-033190.hdr.sgml : 20190529 20190529162513 ACCESSION NUMBER: 0001209191-19-033190 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190528 FILED AS OF DATE: 20190529 DATE AS OF CHANGE: 20190529 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Duvall Martin J CENTRAL INDEX KEY: 0001313390 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38052 FILM NUMBER: 19862317 MAIL ADDRESS: STREET 1: MGI PHARMA, INC. STREET 2: 5775 WEST OLD SHAKOPEE ROAD, SUITE 100 CITY: BLOOMINGTON STATE: MN ZIP: 55437 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Tocagen Inc CENTRAL INDEX KEY: 0001419041 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 261243872 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4242 CAMPUS POINT COURT, SUITE 500 CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: (858) 412-8400 MAIL ADDRESS: STREET 1: 4242 CAMPUS POINT COURT, SUITE 500 CITY: SAN DIEGO STATE: CA ZIP: 92121 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-05-28 0 0001419041 Tocagen Inc TOCA 0001313390 Duvall Martin J C/O TOCAGEN INC. 4242 CAMPUS POINT COURT, SUITE 500 SAN DIEGO CA 92121 1 1 0 0 Chief Executive Officer Common Stock 2019-05-28 4 P 0 5000 4.3357 A 13605 D Includes 1,566 shares of Common Stock that were acquired by the Reporting Person on June 8, 2018 pursuant to the Issuer's Employee Stock Purchase Plan and 968 shares of Common Stock that were acquired by the Reporting Person on December 10, 2018 pursuant to the Issuer's Employee Stock Purchase Plan. /s/ Mark Foletta, Attorney-in-Fact 2019-05-29